Literature DB >> 24627861

The evaluations of frequency distribution heparin resistance during coronary artery bypass graft.

Kaivan Bagheri1, Azim Honarmand1, Mohammadreza Safavi1, Parviz Kashefi1, Lale Sayadi1, Leila Mohammadinia1.   

Abstract

BACKGROUND: Heparin is one of the most important medication that is used in coronary artery bypass graft (CABG) operations, but some patients demonstrate heparin resistance (HR) during CABG. Heparin resistance was defined as at least one activated clothing time <400 seconds after heparinization and/or the need for purified antithrombin III (AT-III) administration. The goal of this study was the investigation of HR prevalence in our country and relation between HR and post-operative CABG complications.
MATERIALS AND METHODS: One hundred patients that candidate for CABG were selected and surveyed for HR and complications. The data entered to computer and analyzed by SPSS soft ware. The Chi-square and student t-tests were used for data analysis.
RESULTS: The prevalence of heparin resistance in our study was 3%. There was no relation among bleeding, cardiac arrest and HR. Bleeding happened in 13 patients of which 1 person was in HR group (33.3%) and 12 in non HR group (12.4%) (P = 0.34). Cardiac arrest happened in 8 patients, 1 person was in HR group (33.3%) and 7 in non HR group (7.2%) (P = 0.22). According our data there were no relation among HR and gender and ventilator dependency time.
CONCLUSIONS: HR is a nearly prevalent complication among patients that undergone CABG that may led to some complications such as bleeding and cardiac arrest. In our study, we did not find significant relation among them, but in frequency these complications were higher in HR group.

Entities:  

Keywords:  Bleeding; coronary artery bypass graft; heparin; heparin complication; heparin resistance

Year:  2014        PMID: 24627861      PMCID: PMC3950837          DOI: 10.4103/2277-9175.125798

Source DB:  PubMed          Journal:  Adv Biomed Res        ISSN: 2277-9175


  14 in total

Review 1.  Redo sternotomy for cardiac reoperations using peripheral heparin-bonded cardiopulmonary bypass circuits without systemic heparinization: technique and results.

Authors:  Arun K Singh; Gary Stearns; Andrew Maslow; William C Feng; Carl Schwartz
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-08-30       Impact factor: 2.628

2.  Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery.

Authors:  Shahar Bar-Yosef; Heidi B Cozart; Barbara Phillips-Bute; Joseph P Mathew; Hilary P Grocott
Journal:  Can J Anaesth       Date:  2007-02       Impact factor: 5.063

3.  The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting.

Authors:  K W Denson
Journal:  Thromb Res       Date:  1977-01       Impact factor: 3.944

Review 4.  Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations.

Authors:  Sean Garvin; Daniel Fitzgerald; Jochen D Muehlschlegel; Tjörvi E Perry; Amanda A Fox; Stanton K Shernan; Charles D Collard; Sary Aranki; Simon C Body
Journal:  Anesth Analg       Date:  2010-02-08       Impact factor: 5.108

5.  Antithrombin III in patients treated with subcutaneous or intravenous heparin.

Authors:  J Conard; T Lecompte; M H Horellou; B Cazenave; M Samama
Journal:  Thromb Res       Date:  1981-05-15       Impact factor: 3.944

6.  Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment.

Authors:  R A Esposito; A T Culliford; S B Colvin; S J Thomas; H Lackner; F C Spencer
Journal:  J Thorac Cardiovasc Surg       Date:  1983-03       Impact factor: 5.209

Review 7.  [Heparin resistance and antithrombin deficiency].

Authors:  Norbert Maurin
Journal:  Med Klin (Munich)       Date:  2009-06-16

Review 8.  [Heparin-induced thrombocytopenia].

Authors:  Dagmara Reingardiene
Journal:  Medicina (Kaunas)       Date:  2008       Impact factor: 2.430

9.  Preoperative intraaortic balloon pumping improves outcomes for high-risk patients in routine coronary artery bypass graft surgery.

Authors:  Giuseppe Santarpino; Francesco Onorati; Antonino S Rubino; Karim Abdalla; Santo Caroleo; Ermenegildo Santangelo; Attilio Renzulli
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330

10.  The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass.

Authors:  W Dietrich; M Spannagl; W Schramm; W Vogt; A Barankay; J A Richter
Journal:  J Thorac Cardiovasc Surg       Date:  1991-10       Impact factor: 5.209

View more
  3 in total

1.  Preoperative Low-Molecular-Weight Heparin Prophylaxis Associated with Increased Heparin Resistance Frequency in On-Pump Coronary Artery Bypass Graft Surgery.

Authors:  Onur Saydam; Mehmet Atay; Deniz Serefli; Suat Doganci; Ulas Kumabasar; Mustafa Yılmaz; Rıza Dogan; Metin Demircin
Journal:  Cardiol Res Pract       Date:  2019-04-16       Impact factor: 1.866

Review 2.  Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review.

Authors:  Mirjam Bachler; Lars M Asmis; Jürgen Koscielny; Thomas Lang; Hartmuth Nowak; Patrick Paulus; Jens-Christian Schewe; Christian von Heymann; Dietmar Fries
Journal:  Blood Coagul Fibrinolysis       Date:  2022-06-08       Impact factor: 1.061

3.  A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra®) in Critically Ill Patients with Heparin Resistance.

Authors:  Mirjam Bachler; Tobias Hell; Johannes Bösch; Benedikt Treml; Bettina Schenk; Benjamin Treichl; Barbara Friesenecker; Ingo Lorenz; Daniel Stengg; Stefan Hruby; Bernd Wallner; Elgar Oswald; Mathias Ströhle; Christian Niederwanger; Christian Irsara; Dietmar Fries
Journal:  J Clin Med       Date:  2020-03-31       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.